NATURAL HISTORY OF HEPATITIS B

Similar documents
Natural History of HBV Infection

HBV PUBLIC HEALTH IMPLICATIONS

HBV NATURAL HISTORY. Mitchell L. Shiffman, MD Director Liver Institute of Virginia Bon Secours Health System Richmond and Newport News, Virginia

An Update HBV Treatment

Role of Hepatitis B Virus Genotypes in Chronic Hepatitis B Exacerbation

Whats new on HBsAg and other markers for HBV infection? Christoph Höner zu Siederdissen

Clinical Management of Hepatitis B WAN-CHENG CHOW DEPARTMENT OF GASTROENTEROLOGY & HEPATOLOGY SINGAPORE GENERAL HOSPITAL

Natural History of Chronic Hepatitis B

Cornerstones of Hepatitis B: Past, Present and Future

Viral Hepatitis. Dr Melissa Haines Gastroenterologist Waikato Hospital

Diagnostic Methods of HBV and HDV infections

Treatment of chronic hepatitis B 2013 update

Chronic Hepatitis B: management update.

ARTICLE IN PRESS. A Treatment Algorithm for the Management of Chronic Hepatitis B Virus Infection in the United States: An Update

CURRENT TREATMENT. Mitchell L Shiffman, MD Director Liver Institute of Virginia Bon Secours Health System Richmond and Newport News, Virginia

Long-term Clinical Outcomes and Risk of Hepatocellular Carcinoma in Chronic Hepatitis B Patients with HBsAg Seroclearance

Diagnostic Methods of HBV infection. Zohreh Sharifi,ph.D of Virology Research center, Iranian Blood Transfusion Organization (IBTO)

Choice of Oral Drug for Hepatitis B: Status Asokananda Konar

Chronic Hepatitis B Infection

Basics of hepatitis B diagnostics. Dr Emma Page MRCP MD(Res) Locum Consultant Sexual Health & Virology

Hepatitis B. ECHO November 29, Joseph Ahn, MD, MS Associate Professor of Medicine Director of Hepatology Oregon Health & Science University

White Nights of Hepatology 2016

Occult Hepatitis B Infection: why, who and what to do?

Maitines septiembre de 2011 Francisco Jorquera Plaza

Don t interfere My first choice is always nucs!

Dr David Rowbotham NHS. The Leeds Teaching Hospitals. NHS Trust

Management of Chronic Hepatitis B in Asian Americans

Hepatitis B virus infection. Chow Wan Cheng Dept of Gastroenterology & Hepatology Singapore General Hospital

Hepatitis B. What's the impact on the risk? Dr Himanshu Bhatia, Asia Chief Medical Officer ALUCA, Brisbane, Sept 2013

Hepatitis B screening and surveillance in primary care

APPROACH TO A PATIENT WITH CHRONIC HEPATITIS B INFECTION. Dr. Mohammad Zahiruddin Associate Professor Department of Medicine Dhaka Medical College

Chronic hepatitis B virus (HBV) infection remains a major

Management of Hepatitis B - Information for primary care providers

Viral Hepatitis Diagnosis and Management

Hepatitis B Epidemiology and Prevention in the Elimination Era John W. Ward, MD

PROPOSAL FOR THE DEVELOPMENT OF AN INTERNATIONAL REFERENCE PREPARATION FOR HEPATITIS D VIRUS RNA

29th Viral Hepatitis Prevention Board Meeting

Hepatitis C. Core slides

Hepatitis B. Epidemiology and Natural History and Implications for Treatment

Media centre. WHO Hepatitis B. Key facts. 1 of :12 AM.

Received 30 May 2004/Returned for modification 6 August 2004/Accepted 12 August 2004

BSG/ACP annual course Royal College of Pathologists Infections and Inflammations of the Hepato-Biliary System Hepatitis B and D

THE IMPACT OF HLA CLASS I ON VIROLOGICAL OUTCOMES OF HBV

Learning Objectives: Hepatitis Update. Primary Causes of Chronic Liver Disease in the U.S. Hepatitis Definition. Hepatitis Viruses.

JMSCR Volume 03 Issue 01 Page January 2015

What have we learned from HBV clinical cohorts?

Clinical Case Maria Butí, MD, PhD

Global Perspective on the Natural History of Chronic Hepatitis B: Role of Hepatitis B Virus Genotypes A to J

Consensus AASLD-EASL HBV Treatment Endpoint and HBV Cure Definition

HBsAg Quantification: Should It be Part of The Treatment Algorithm for CHB? Stephen N. Wong, MD

Acute Hepatitis B Virus Infection with Recovery

Management of chronic hepatitis B : recent advance in the treatment of antiviral resistance

Hepatitis B Virus infection: virology

IN THE NAME OF GOD. D r. MANIJE DEZFULI AZAD UNIVERCITY OF TEHRAN BOOALI HOSPITAL INFECTIOUS DISEASES SPECIALIST

Molecular Testing in the Diagnosis and Management of Chronic Hepatitis B

Epidemiology of hepatitis B and D in Greece

HBeAg-negative chronic hepatitis B. with a nucleos(t)ide analogue?

Alla ricerca del virus nascosto (quando il virus dell epatitie B si occulta )

C hronic hepatitis B (CHB) virus infection affects more

Optimized HBV Treatment Through Baseline and on-treatment Predictor Oral Antiviral Therapy. Watcharasak Chotiyaputta

HBV Diagnosis and Treatment

Hepatitis B Update. Jorge L. Herrera, M.D. University of South Alabama Mobile, AL. Gastroenterology

Therapeutic Guidelines on Management of Chronic Hepatitis B in Asia

Serum Hepatitis B Surface Antigen Levels Help Predict Disease Progression in Patients With Low Hepatitis B Virus Loads. Hepatology Feb 2013

Development of Hepatocellular Carcinoma After Seroclearance of Hepatitis B Surface Antigen

EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection

March 29, :15 PM 1:15 PM San Diego, CA Convention Center Ballroom 20D

Hepatitis B Diagnosis and Management. Marion Peters University of California San Francisco

HBV: the same than HCV?

Viral hepatitis and Hepatocellular Carcinoma

Understanding HBV Testing: HBsAg, HBV RNA, cccdna, HBeAg and HBcrAg in Context of Antiviral Drug Development

HEPATITIS B: are escape mutants of concern?

Hepatitis B: A Preventable Cause of Liver Cancer. Saira Khaderi MD, MPH Assistant Professor of Surgery Associate Director, Project ECHO June 17, 2016

Hepatitis Serology and Background Notes

Review HBV genotypes: relevance to natural history, pathogenesis and treatment of chronic hepatitis B

Mortality from viral hepatitis in the Netherlands. S.W. Schalm & M.Toy. Dpts Gastroenterology Hepatology and Public Health Erasmus MC, Rotterdam, NL

4th International HIV/Viral Hepatitis Co-Infection Meeting

Supplementary materials: Predictors of response to pegylated interferon in chronic hepatitis B: a

Hepatitis B Treatment Pearls. Agenda

MANAGEMENT OF HBV & HCV INFECTION---SIMILARITIES & DISSIMILARITIES---PAST AND PRESENT. Professor Salimur Rahman

Test Name Results Units Bio. Ref. Interval

Hepatitis. Dr. Mohamed. A. Mahdi 5/2/2019. Mob:

HBeAg-positve chronic hepatts B: Why do I treat my patent with a NA? Maria But

La riattivazione dell epatite virale nel paziente in terapia biologica

Hepatitis B and D Update on clinical aspects

DILEMMAS IN THE MANAGEMENT OF CO-INFECTION IN HIV-INFECTED CHILDREN

Bible Class: Hepatitis B Virus Infection

Hepatocellular Carcinoma: Can We Slow the Rising Incidence?

KASL Clinical Practice Guidelines: Management of chronic hepatitis B

Short title: BENEFIT STUDY, STUDY REPORT (ML25614) Synopsis/Abstract

Diagnosis and Management of Chronic Hepatitis B virus Infection

HBV in HIV Forgotten but not Gone

HEPATITIS B: WHO AND WHEN TO TREAT?

Yuen, MF; Sablon, E; Yuan, HJ; Hui, CK; Wong, DKH; Doutreloigne, J; Wong, BCY; Chan, AOO; Lai, CL

The Alphabet Soup of Viral Hepatitis Testing

Spontaneous hepatitis B e antigen (HBeAg) seroconversion

Professor Vincent Soriano

Sojan George Kunnathuparambil, Kattoor Ramakrishnan Vinayakumar, Mahesh R. Varma, Rony Thomas, Premaletha Narayanan, Srijaya Sreesh

Chronic infection with hepatitis B virus (HBV) is still a

Eliminating Chronic Hepatitis B Disparities among Asian Pacific Islanders: A Model for Transforming Public Health in the Pacific

Transcription:

NATURAL HISTORY OF HEPATITIS B AND DIAGNOSTIC: STATE OF THE ART O. BAHRI LABORATORY OF MEDICAL BIOLOGY AZIZA OTHMANA HOSPITAL TUNIS, TUNISIA The 2 nd Congress of The Federation of Arab Societies of Clinical Microbiology and Infectious Diseases Tunisia, 24 26 May 2012

HEPATITIS B = GLOBAL HEALTH PROBLEM One of the most common chronic viral infections HBV contact 2 billion HBV chronically infected 350 400 million Death Ranked cause of cancer Ranked cause of death by cancer 1 million annually 5 th worldwide 3 th worldwide Mutimer D et al, Medicine 2011

HEPATITIS B = GLOBAL HEALTH PROBLEM High endemicity: - Asia - Africa - Parts of southern, eastern Europe El Gouhari H et al, Cleveland Clin. J. Med 2008

NATURAL HISTORY OF HBV INFECTION HBV infection = a dynamic process VIRAL REPLICATION HOST IMMUNE RESPONSE - Course of viral infection - Severity of liver damage

NATURAL HISTORY OF HBV INFECTION Immune response against HBV infection Ganem D, NEJM 2004

NATURAL HISTORY OF HEPATITIS B Acute HBV infection Immune response is adequate CD8+ Immune response is enhanced CD8+ HBV clearance Moderate liver damage Resolved form HBV clearance Massive liver damage Fulminant form Lok AS and McMahon BJ. Hepatology 2007;45:507-39

NATURAL HISTORY OF HEPATITIS B Acute HBV infection - Fulminant form is characterised by: - Presence of IgM against HBcAg - Absence of HBV DNA Ganem D, NEJM 2004

NATURAL HISTORY OF HEPATITIS B Acute HBV infection Chronic infection - Inefficient Immune response -cccdna in hepatocytes Progressive chronic hepatitis Inactive carrier state 2% - 6%/year Cirrhosis 2.5% - 5%/year Death HCC Lok AS and McMahon BJ. Hepatology 2007;45:507-39

ROLE OF AGE OF CONTAMINATION IN THE EVOLUTION OF HEPATITIS B Acute HBV infection Perinatal Early childhood Adult 20-50% 10% 95% Resolved infection Chronic infection Resolved infection Chronic infection El Gouhari H et al, Cleveland Clin. J. Med 2008

NATURAL HISTORY OF CHRONIC HEPATITIS B

IMMUNOTOLERANT PHASE > 10 8 cp/ml

IMMUNOCLEARANCE PHASE > 10 5 cp/ml

INACTIVE CARRIER STATE < 10 4 cp/ml

REACTIVATION PHASE > 10 4 cp/ml

SEROLOGICAL AND VIROLOGICAL PROFILES FOR STATES OF INFECTION

QUANTIFICATION OF HBV DNA 1 10 10 2 10 3 10 4 10 5 10 6 10 7 10 8 10 9 HBV Digene Hybrid-Capture II 10 10 Ultra-sensitive HBV Digene Hybrid-Capture II Versant HBV DNA 3.0 Assay Amplicor HBV Monitor Cobas Amplicor HBV Monitor Cobas Taqman HBV Real-Art HBV PCR Assay

QUANTIFICATION OF HBV DNA Objectives: - Determine the state of chronic infection - Survey evolution of chronic hepatitis B - Explore viral reactivation - Indicate and monitor treatment - Detect an emergence of resistant mutants to treatment

NEW DIAGNOSTIC TOOLS cccdna Quantification infected of cccdna liver cell in burden biopsy

NEW DIAGNOSTIC TOOLS QUANTIFICATION OF HBSAG A useful new tool for monitoring and optimization of hepatitis B treatments - Levels of serum HBsAg and intrahepatic cccdna are closely correlated - HBsAg quantification = indirect reflect of the number of infected hepatocytes. - The decline of HBsAg levels in serum = A predictive marker for sustained virological response, and clearance of HBsAg.

NATURAL HISTORY OF HEPATITIS B Acute HBV infection Chronic infection Progressive chronic hepatitis Inactive carrier state 2% - 6%/year Cirrhosis 2.5% - 5%/year Death HCC Lok AS and McMahon BJ. Hepatology 2007;45:507-39

RISK FACTORS FOR SEVERE EVOLUTION OF CHRONIC HEPATITIS 1- Host factors 2- Host-viral interaction 3- Viral factors Xu H; Current Hepatitis Rec 2011

RISK FACTORS FOR SEVERE EVOLUTION OF CHRONIC HEPATITIS HOST FACTORS Strentgh of association Male ++ Age> 40y ++ Genetic susceptibility? (under evaluation) (polymorphism of IL10, IL18 ) Family history of HCC + Regular alcohol consumption +/- Xu H; Current Hepatitis Rec 2011

RISK FACTORS FOR SEVERE EVOLUTION OF CHRONIC HEPATITIS HOST-VIRAL INTERACTIONS Risk Factors Strength of association Cirrhosis ++ ALT levels + ALT levels = poor predictor for progression to severe forms especially the reactivation phase (fluctuation of ALT) Xu H; Current Hepatitis Rec 2011

RISK FACTORS FOR SEVERE EVOLUTION OF CHRONIC HEPATITIS VIRAL FACTORS Risk Factors Strength of association High HBV DNA levels ++ Genotype C + Mutations Precore mutation - Core Promoter mutation ++ Pre-S + HBx + Xu H; Current Hepatitis Rec 2011

RISK FACTORS FOR SEVERE EVOLUTION OF CHRONIC HEPATITIS HBV DNA LEVELS REVEAL HBV study: Population-based prospective cohort in Taiwan (3582 HBV carriers) Cirrhosis HCC Kao J; Hepatol intern 2007

RISK FACTORS FOR SEVERE EVOLUTION OF CHRONIC HEPATITIS VIRAL GENOTYPES Risk for HCC D > A C > B Hadzyanis S; J. Hepatology 2011

RISK FACTORS FOR SEVERE EVOLUTION OF CHRONIC HEPATITIS Pre-S deletion VIRAL MUTATIONS Nt 1766/1768 Nt 1653/1753 Kao J; Hepatol intern 2007

RISK FACTORS FOR SEVERE EVOLUTION OF CHRONIC HEPATITIS OTHER RISK FACTORS Kao J; Hepatol intern 2007

RISK FACTORS AND PREDICTIVE SCORES Some authors proposed predictive scores To monitor treatment and to survey HCC

RISK FACTORS AND PREDICTIVE SCORES Yuen MF et al. 2009 Yang et al. 2010 Wong et al. 2010 Studied population Parameters used 820 untreatedpatients with CHB 3600 HBV infected patients 1000 HBV infected patients Age Gender HBV DNA level Core/BCP mutations Cirrhosis Sex Age Family history of HCC Alcohol HBeAg HBV DNA level HBV genotype Age Albumin Bilirubin HBV DNA level Cirrhosis Predictive scores must be evaluated before introduction in routine

CONCLUSION Characteristics of chronic hepatitis B Complexity High variabiliy Implication of several risk factors Cohort studies in differents parts of the world are needed to best: Understanding of the evolution for HBV infection Monitoring of chronic infection